- tremors / MGI
- muscle degeneration / MGI
- myopathy / MGI
- abnormal skeletal muscle morphology / MGI
- abnormal neuromuscular synapse morphology / MGI
- postnatal growth retardation / MGI
- abnormal endplate potential / MGI
- abnormal skeletal muscle fiber morphology / MGI
- abnormal cell adhesion / MGI
- abnormal Z line morphology / MGI
- abnormal sarcolemma morphology / MGI
- abnormal basement membrane morphology / MGI
- myositis / MGI
- abnormal synaptic vesicle morphology / MGI
- abnormal miniature endplate potential / MGI
- abnormal synaptic acetylcholine release / MGI
- increased susceptibility to injury / MGI
- decreased skeletal muscle fiber diameter / MGI
- impaired exercise endurance / MGI
FVB.129S6(B6)-Col13a1tm4.1Pih/Oulu
| Status | Available to order |
| EMMA ID | EM:09913 |
| Citation information | RRID:IMSR_EM:09913 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | FVB.129S6(B6)-Col13a1tm4.1Pih/Oulu |
| Alternative name | FVB.129S6-Col13a1 |
| Strain type | Targeted Mutant Strains : Knock-in |
| Allele/Transgene symbol | Col13a1tm4.1Pih |
| Gene/Transgene symbol | Col13a1 |
Information from provider
| Provider | Taina Pihlajaniemi |
| Provider affiliation | Faculty of Biochemistry and Molecular medicine, University of Oulu |
| Genetic information | Furin/Furin type proprotein convertase recognition sequence RRRR in the exon 2 of Col13a1 was mutated to ATAA. Neomycin-resistance cassette was placed about 150 nt upstream from the exon 2. Cassette was later removed by crossbreeding with a constitutive cre-expressing line to leave behind one loxP site and some cloning sequences at the end of intron 1. |
| Phenotypic information | Homozygous:Altered neuromuscular junction maturation, function and stabilityHeterozygous:None |
| Breeding history | ES cell line used was W4 (129S6/SvEvTac). Only one correctly targeted clone was identified. Mice were backcrossed for 6 generations to C57BL/6JOlaHsd after which they were crossed with Tg(CAG-cre)13Miya mice (maintained in-house; backcrossed to C57BL/6JOlaHsd), to exclude loxP-flanked neomycin-resistance cassette. Mice were backcrossed with C57BL/6JOlaHsd mice for 10 more generation after which they were backcrossed with FVB mice for 7 generations. |
| References |
|
| Homozygous fertile | yes |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | University of Oulu, Oulu, Finland |
| Animals used for archiving | homozygous FVB males |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Postsynaptic congenital myasthenic syndromes / Orphanet_98913
- Presynaptic congenital myasthenic syndromes / Orphanet_98914
MGI phenotypes (gene matching)
Literature references
- Collagen XIII secures pre- and postsynaptic integrity of the neuromuscular synapse.;Härönen Heli, Zainul Zarin, Tu Hongmin, Naumenko Nikolay, Sormunen Raija, Miinalainen Ilkka, Shakirzyanova Anastasia, Oikarainen Tuomo, Abdullin Azat, Martin Paula, Santoleri Sabrina, Koistinaho Jari, Silman Israel, Giniatullin Rashid, Fox Michael A, Heikkinen Anne, Pihlajaniemi Taina, ;2017;Human molecular genetics;26;2076-2090; 28369367
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
